Visit of Facilities. Representatives of either party may, upon reasonable notice and at times reasonably acceptable to the other party, (i) visit the facilities where the activities relating to the collaboration are being conducted; and (ii) consult informally, during such visits and by telephone, with personnel of the other party performing such activities. Each party shall bear its own expenses with regard to any such visits, unless otherwise agreed upon in writing by the parties. If requested by the other party, the parties each shall cause appropriate individuals working on the activities relating to the collaboration to be available for meetings at the location of the facilities where such individuals are employed at times reasonably convenient to each party.
Appears in 3 contracts
Samples: Collaboration Agreement (Ecology Coatings, Inc.), Collaboration Agreement (Ecology Coatings, Inc.), Collaboration Agreement (Ecology Coatings, Inc.)
Visit of Facilities. Representatives of either party may, upon reasonable notice and at times a frequency reasonably acceptable to the other party, Other party during normal business hours (ia) visit the facilities where the activities relating to the collaboration are Research and Development is being conducted; and (iib) consult informally, during such visits and by telephone, with personnel of the other party performing such activitiesthe Research and Development. Each party shall bear its own expenses with regard to any such visits, unless otherwise agreed upon in writing by the parties. If requested by the other party, the parties each Neurocrine and Rigel shall cause appropriate individuals working on the activities relating to the collaboration Research and Development to be available for meetings at the location of the facilities where such individuals are employed at times reasonably convenient to each party.
Appears in 2 contracts
Samples: Collaborative Research and Development Agreement (Rigel Pharmaceuticals Inc), Collaborative Research and Development Agreement (Rigel Pharmaceuticals Inc)